Vivasure Medical Limited
11
1
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
33%
2 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
PerQseal® Elite Venous Clinical Study (ELITE-Venous)
Role: lead
PerQseal® Clinical Study
Role: lead
Safety and Performance Study for Arterial Large Hole Vascular Closure Device
Role: lead
PerQseal®+ Early Feasibility Study
Role: lead
PerQseal® Impella Early Feasibility Study
Role: lead
Safety and Performance Study of Large Hole Vascular Closure Device FIV
Role: lead
Safety and Performance Study of Large Hole Vascular Closure Device - France
Role: lead
Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER V Study
Role: lead
Safety and Performance Study of Large Hole Vascular Closure Device
Role: lead
Safety and Performance Study of Large Hole Vascular Closure Device
Role: lead
Safety and Performance Study of Large Hole Vascular Closure Device
Role: lead
All 11 trials loaded